Dermata Therapeutics, Inc. (DRMAW)
DRMAW Stock Price Chart
Explore Dermata Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DRMAW price movements and trends.
DRMAW Company Profile
Discover essential business fundamentals and corporate details for Dermata Therapeutics, Inc. (DRMAW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Aug 2021
Employees
9.00
Website
http://www.dermatarx.comCEO
Gerald T. Proehl
Description
Dermata Therapeutics, Inc., a biotechnology company in the clinical development stage, is headquartered in San Diego, California, and was established in 2014. The firm's core mission is to develop innovative treatments for a variety of dermatological and cosmetic skin conditions. Its flagship investigational product, DMT310, is a topical formula applied once weekly that is currently undergoing clinical trials. This primary compound is being evaluated for its effectiveness against acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. Additionally, the company is advancing DMT410, which is intended to address hyperhidrosis (excessive sweating) and other aesthetic concerns.
DRMAW Financial Timeline
Browse a chronological timeline of Dermata Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Aug 2026
EPS estimate is -$0.55.
Earnings released on 13 May 2026
EPS came in at -$0.48 surpassing the estimated -$0.53 by +9.43%.
Earnings released on 26 Mar 2026
EPS came in at -$0.35 surpassing the estimated -$1.54 by +77.27%.
Earnings released on 14 Nov 2025
EPS came in at -$1.65 falling short of the estimated -$1.59 by -3.67%.
Earnings released on 13 Aug 2025
EPS came in at -$1.66 surpassing the estimated -$2.90 by +42.86%.
Earnings released on 14 May 2025
EPS came in at -$0.45 surpassing the estimated -$4.50 by +90.07%.
Earnings released on 30 Sept 2023
EPS came in at -$0.54 .
Earnings released on 30 Jun 2023
EPS came in at -$1.73 .
Earnings released on 31 Mar 2023
Earnings released on 31 Dec 2022
EPS came in at -$0.13 .
DRMAW Stock Performance
Access detailed DRMAW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
